All Stories

  1. Characterization of D4Z4 alleles and assessment of de novo cases in Facioscapulohumeral dystrophy (FSHD) in a cohort of Italian families
  2. Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study
  3. 255th ENMC workshop: Muscle imaging in idiopathic inflammatory myopathies. 15th January, 16th January and 22nd January 2021 – virtual meeting and hybrid meeting on 9th and 19th September 2022 in Hoofddorp, The Netherlands
  4. Muscle magnetic resonance imaging of a large cohort of distal hereditary motor neuropathies reveals characteristic features useful for diagnosis
  5. Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations
  6. Whole exome sequencing highlights rare variants in CTCF, DNMT1, DNMT3A, EZH2 and SUV39H1 as associated with FSHD
  7. Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis
  8. A comprehensive study of skeletal muscle imaging in FHL1‐related reducing body myopathy
  9. Correction: Differential effects of mutations of POPDC proteins on heteromeric interaction and membrane trafficking
  10. Early Muscle MRI Findings in a Pediatric Case of Emery-Dreifuss Muscular Dystrophy Type 1
  11. Long-term clinical and MRI follow-up in two POMT2-related limb girdle muscular dystrophy (LGMDR14) patients
  12. Artificial Intelligence for Evaluation of Retinal Vasculopathy in Facioscapulohumeral Dystrophy Using OCT Angiography: A Case Series
  13. Decoding Duchenne muscular dystrophy transcriptome to single nuclei level reveals clinical-genetic correlations
  14. Radiomics and machine learning applied to STIR sequence for prediction of quantitative parameters in facioscapulohumeral disease
  15. ANCA-negative microscopic polyangiitis with neuromuscular involvement: When pathology could make the difference
  16. Meeting report: The 2022 FSHD International Research Congress
  17. Using Cluster Analysis to Overcome the Limits of Traditional Phenotype–Genotype Correlations: The Example of RYR1-Related Myopathies
  18. Differential effects of mutations of POPDC proteins on heteromeric interaction and membrane trafficking
  19. 265th ENMC International Workshop: Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22–24 April 2022, Hoofddorp, The Netherlands
  20. D4Z4 Methylation Levels Combined with a Machine Learning Pipeline Highlight Single CpG Sites as Discriminating Biomarkers for FSHD Patients
  21. NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy
  22. Correction to: New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy
  23. Differential Effects of Mutations of Popeye Domain Containing Proteins on Heteromeric Interaction and Membrane Trafficking
  24. Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients
  25. European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders
  26. Genotype–phenotype correlations in valosin-containing protein disease: a retrospective muticentre study
  27. Dynamic magnetic resonance imaging of muscle contraction in facioscapulohumeral muscular dystrophy
  28. Upper body involvement in GNE myopathy assessed by muscle imaging
  29. Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study
  30. Muscle-MRI and Functional Levels for the Evaluation of Upper Limbs in Duchenne Muscular Dystrophy: A Critical Review of the Literature
  31. Technology outcome measures in neuromuscular disorders: A systematic review
  32. Muscle inflammatory pattern in alpha- and gamma-sarcoglycanopathies
  33. Deep learning for automatic segmentation of thigh and leg muscles
  34. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort
  35. High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients
  36. Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning
  37. 1st FSHD European Trial Network workshop:Working towards trial readiness across Europe
  38. Thr124Met myelin protein zero mutation mimicking motor neuron disease
  39. Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy
  40. Redox Homeostasis in Muscular Dystrophies
  41. Dynamic magnetic resonance imaging of muscle contraction in facioscapulohumeral muscular dystrophy
  42. Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis
  43. Eyelid closing and opening disorders in patients with unilateral brain lesions: A case report with video neuroimage and a systematic review of the literature
  44. INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH
  45. Fast Open-Source Toolkit for Water T2 Mapping in the Presence of Fat From Multi-Echo Spin-Echo Acquisitions for Muscle MRI
  46. Texture analysis and machine learning to predict water T2 and fat fraction from non-quantitative MRI of thigh muscles in Facioscapulohumeral muscular dystrophy
  47. Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy
  48. 247th ENMC International Workshop: Muscle magnetic resonance imaging - Implementing muscle MRI as a diagnostic tool for rare genetic myopathy cohorts. Hoofddorp, The Netherlands, September 2019
  49. 250th ENMC International Workshop: Clinical trial readiness in nemaline myopathy 6–8 September 2019, Hoofdorp, the Netherlands
  50. A Recurrent Pathogenic Variant of INPP5K Underlies Autosomal Recessive Congenital Muscular Dystrophy With Cataracts and Intellectual Disability: Evidence for a Founder Effect in Southern Italy
  51. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy
  52. Peculiar muscle imaging findings in a patient with alphaB-crystallinopathy and axial myopathy
  53. Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging
  54. Genotype–phenotype correlations in recessive titinopathies
  55. Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in SCN4A in a Large Cohort of Italian Patients
  56. Response to: SOD1 mutations in adult‐onset distal spinal muscular atrophy
  57. SOD1 p.D12Y variant is associated with amyotrophic lateral sclerosis/distal myopathy spectrum
  58. Accuracy of a machine learning muscle MRI-based tool for the diagnosis of muscular dystrophies
  59. MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients
  60. MYO-MRI diagnostic protocols in genetic myopathies
  61. Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging
  62. Glycogenin is Dispensable for Glycogen Synthesis in Human Muscle, and Glycogenin Deficiency Causes Polyglucosan Storage
  63. The variability of SMCHD1 gene in FSHD patients: evidence of new mutations
  64. European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)
  65. A man with sarcoidosis and slurred speech
  66. Cytidine Diphosphate-Ribitol Analysis for Diagnostics and Treatment Monitoring of Cytidine Diphosphate-l-Ribitol Pyrophosphorylase A Muscular Dystrophy
  67. Impairments in contractility and cytoskeletal organisation cause nuclear defects in nemaline myopathy
  68. Central nervous system immune reconstitution inflammatory syndrome after autologous stem cell transplantation
  69. An unusual ryanodine receptor 1 (RYR1) phenotype
  70. Advances in Quantitative Imaging of Genetic and Acquired Myopathies: Clinical Applications and Perspectives
  71. Muscle hypertrophy in amyloid myopathy
  72. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy
  73. Functional levels and MRI patterns of muscle involvement in upper limbs in Duchenne muscular dystrophy
  74. Interpreting Genetic Variants in Titin in Patients With Muscle Disorders
  75. Expanding the histopathological spectrum of CFL2 -related myopathies
  76. Hereditary myopathy with early respiratory failure (HMERF): Still rare, but common enough
  77. Novel Homozygous KCNJ10 Mutation in a Patient with Non-syndromic Early-Onset Cerebellar Ataxia
  78. Neuromyopathy with congenital cataracts and glaucoma: a distinct syndrome caused by POLG variants
  79. Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort
  80. Somatic mosaicism represents an underestimated event underlying collagen 6-related disorders
  81. MRI in sarcoglycanopathies: a large international cohort study
  82. Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients
  83. 1st International Workshop on Clinical trial readiness for sarcoglycanopathies 15–16 November 2016, Evry, France
  84. Facilitating orphan drug development: Proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA
  85. Erratum to: Muscle MRI in neutral lipid storage disease (NLSD)
  86. Diagnostic anoctamin-5 protein defect in patients with ANO5-mutated muscular dystrophy
  87. Muscle MRI in neutral lipid storage disease (NLSD)
  88. Concentric muscle involvement in POLG -related distal myopathy
  89. Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy
  90. Novel mutations in KARS cause hypertrophic cardiomyopathy and combined mitochondrial respiratory chain defect
  91. Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity
  92. Association study reveals novel risk loci for sporadic inclusion body myositis
  93. To the Editor
  94. Rinsing after spinning: plasmapheresis in EBV-related post-infectious cerebellitis
  95. Matrin 3 variants are frequent in Italian ALS patients
  96. Targeted Next-Generation Sequencing Reveals Novel TTN Mutations Causing Recessive Distal Titinopathy
  97. The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis
  98. TBCE Mutations Cause Early-Onset Progressive Encephalopathy with Distal Spinal Muscular Atrophy
  99. Start codon mutation of GYG1 causing late-onset polyglucosan body myopathy with nemaline rods
  100. MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients
  101. The genetic basis of undiagnosed muscular dystrophies and myopathies
  102. New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients
  103. Magnetic resonance imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: Pattern refinement and implications for clinical trials
  104. Corrigendum
  105. New ALS-Related Genes Expand theSpectrum Paradigmof Amyotrophic Lateral Sclerosis
  106. Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2
  107. Clinical trial preparedness in facioscapulohumeral muscular dystrophy: Clinical, tissue, and imaging outcome measures 29–30 May 2015, Rochester, New York
  108. POPDC1S201F causes muscular dystrophy and arrhythmia by affecting protein trafficking
  109. Muscle imaging in patients with tubular aggregate myopathy caused by mutations in STIM1
  110. Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis
  111. Muscle imaging in fibrodysplasia ossificans progressiva: The neurologist's perspective
  112. A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease
  113. Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations
  114. Centronuclear myopathies: genotype–phenotype correlation and frequency of defined genetic forms in an Italian cohort
  115. Prevalence of congenital muscular dystrophy in Italy: A population study
  116. Calf muscle involvement in Becker muscular dystrophy: When size does not matter
  117. Isolated semitendinosus involvement in the initial stages of limb-girdle muscular dystrophy 2L
  118. Clinical, histological and genetic characterisation of patients with tubular aggregate myopathy caused by mutations in STIM1
  119. Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy
  120. Childhood onset tubular aggregate myopathy associated with de novo STIM1 mutations
  121. Biochemical Characterization of Patients With In-Frame or Out-of-FrameDMDDeletions Pertinent to Exon 44 or 45 Skipping
  122. Teaching Video NeuroImages: Complicated scapular winging
  123. ‘Pathognomonic’ muscle imaging findings in DNAJB6 mutated LGMD1D
  124. Myotonic dystrophy type 1 and de novo FSHD mutation double trouble: A clinical and muscle MRI study
  125. Hereditary myopathy with early respiratory failure: occurrence in various populations
  126. Centronuclear myopathy related to dynamin 2 mutations: Clinical, morphological, muscle imaging and genetic features of an Italian cohort
  127. Mitochondrial Network Genes in the Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients
  128. Limb-girdle muscular dystrophy with  -dystroglycan deficiency and mutations in the ISPD gene
  129. Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions
  130. Muscle MRI in Becker muscular dystrophy
  131. Somatic mosaicism in TPM2-related myopathy with nemaline rods and cap structures
  132. Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late-onset cerebellar ataxia
  133. New phenotype and pathology features in MYH7-related distal myopathy
  134. Different Molecular Signatures in Magnetic Resonance Imaging-Staged Facioscapulohumeral Muscular Dystrophy Muscles
  135. Muscle MRI in female carriers of dystrophinopathy
  136. Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5
  137. Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy
  138. Muscle imaging findings in GNE myopathy
  139. Multi-organ investigation in 16 CADASIL families from central Italy sharing the same R1006C mutation
  140. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials
  141. An Immunological Analysis of Dystroglycan Subunits: Lessons Learned from a Small Cohort of Non-Congenital Dystrophic Patients
  142. Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies
  143. Abnormal vascular smooth muscle cell proliferation in sural nerve biopsy from a patient with sensorimotor axonal neuropathy
  144. CD8+ T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI
  145. An Italian case of hereditary myopathy with early respiratory failure (HMERF) not associated with the titin kinase domain R279W mutation
  146. A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia
  147. A novel HSPB1 mutation in an Italian patient with CMT2/dHMN phenotype
  148. Mixed connective tissue disease presenting as a peculiar myositis with poor muscle regeneration
  149. Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy
  150. Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia
  151. An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in theVCP gene
  152. Isolation and Characterization of Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy Muscle Biopsies
  153. Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression